RMP
DXCM icon

Richards, Merrill & Peterson’s DexCom DXCM Stock Holding History

Richards, Merrill & Peterson’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-230
Closed -$15.7K – 276
2025
Q1 		$15.7K Hold
230
– – 0.01% 363
2024
Q4 		$17.9K Buy
+230
New +$17K 0.01% 338

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Richards, Merrill & Peterson's DXCM Position: Q2 2025 in Review

Richards, Merrill & Peterson sold out of DexCom (DXCM) in Q2 2025, closing a stake of 230 shares — an estimated $15.7K sold.

Richards, Merrill & Peterson first reported a position in DXCM in Q4 2024 and held it in 2 quarters. The position peaked at $17.9K in Q4 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Richards, Merrill & Peterson reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Richards, Merrill & Peterson sold 230 DexCom shares in Q2 2025, an estimated $15.7K.
  • Richards, Merrill & Peterson first reported a position in DexCom in Q4 2024 and held it in 2 quarters.
  • Richards, Merrill & Peterson's DexCom position peaked at $17.9K in Q4 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2025, filed 31 Jul 2025.